Skip to main content
OpenTrials
Completed

NCT Number: NCT07474246

A Innovative Web-based Dance Movement Therapy

The goal of this clinical trial is to develop an innovative web-based dance movement therapy (DMT) training platform and assess short-term outcomes before and after its implementation in women with breast cancer

Is the DMT training platform comprehensibility and acceptability among patients? Is the DMT training platform acceptability, usability, and feasibility among healthcare providers? Does the DMT training platform have effects on alexithymia and frailty among patients?

Researchers will compare experimental to a control (a a conventional care program) to see if DMT training platform works to treat severe asthma.

Participants will:

receive an orientation on the web-based DMT program before chemotherapy, along with a single face-to-face traditional education session on physical activity .

complete training sessions three times per week, with each session lasting at least 70 min.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Breast Cancer Breast Diseases Breast Neoplasms Neoplasms Neoplasms by Site Skin Diseases Skin and Connective Tissue Diseases

Age range

20 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

National Yang Ming Chiao Tung University

Taipei, Taiwan

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients who were about to start chemotherapy were recruited from a hospital in Taipei, Taiwan

Exclusion criteria

  • major illness (e.g., heart failure, stroke, blindness) or a pre-existing mental disorder
  • a history of limb amputation
  • prior participation in dance therapy before their breast cancer diagnosis

Treatment and study plan

web-based dance movement therapy training intervention

Other

Patients in the experimental group received an orientation on the web-based DMT program before chemotherapy, along with a single face-to-face traditional education session on physical activity. Participants were encouraged to complete training sessions three times per week, with each session lasting at least 70 min. Each DMT training session was divided into four components: (1) Proprioception; (2)Warm-up and stretching techniques; (3) Main part; (4) Relaxation.

Primary outcomes

  1. Alexithymia

    Time frame: one year (2024/08/01-2025/07/31)

    Alexithymia was assessed using the Chinese version of the Toronto Alexithymia Scale (TAS), a self-reported outcome measure [30-31]. The TAS consists of 20 items covering three key domains: difficulty in identifying and discriminating emotional cues, difficulty in verbally expressing emotions and feelings, and externally oriented thinking. Each item was rated on a 5-point Likert scale, ranging from 1 to 5, resulting in a total score range of 20 to 100, with higher scores indicating greater alexithymia.

  2. Frailty

    Time frame: one year ( 2024/08/01-2025/07/31).

    A breast cancer comprehensive frailty scale (BCCFS) was developed to assess frailty across three domains: deterioration in body function and mobility, negative emotional states, and cognitive impairment. The BCCFS comprises 16 items and has demonstrated strong psychometric properties, with a Cronbach's alpha of 0.91, indicating excellent internal consistency, and a test-retest reliability coefficient of 0.60 [32]. The validity and reliability of the BCCFS have been well established. Responses to each item were recorded on a five-point Likert scale, with higher scores indicating greater perceived frailty.

Sponsors and collaborators

Lead sponsor

Chin-Tsung Shen

Other

Collaborators

  • Ministry of Science and Technology, Taiwan

Registry information

Official study title

Developing and Evaluating the Effect of a Innovative Web-based Dance Movement Therapy on Alexithymia and Frailty in Women With Breast Cancer: An Experimental Study

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Mar 16, 2026
Registry last updated
Mar 16, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.